The personal injury lawyers of Aylstock, Witkin, Kreis and Overholtz are investigating claims of acute and severe liver failure affecting people using the weight loss drug, orlistat. The investigation follows a health alert by the Food and Drug Administration (FDA) in August 2009, which received 32 reports of liver damage in orlistat users.
Orlistat is sold by prescription under the brand name Xenical, and over-the-counter under the brand name Alli, the first non-prescription weight loss drug to gain FDA approval in 2007. Orlistat serves as a weight loss aid by blocking the absorption of certain fats in the digestive tract, helping patients lose weight with greater ease.
Orlistat began to attract FDA attention following a report of a woman who developed liver failure and required a liver transplant within weeks of taking orlistat. Since 1999, the FDA has received reports of Xenical liver damage and Alli liver injury, with most patients demonstrating jaundice, fatigue and abdominal pain.
If you have developed liver damage and are taking Xenical or Alli, you may be eligible to file a claim against the manufacturers. To learn more about filing a Xenical or Alli lawsuit, contact AWKO Law today at (888) 255-2956.